ARMISTICE CAPITAL, LLC

Holdings History for Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)

Symbol: AUTL on Nasdaq
Investment type: Equity / American Depositary Shares, each representing one ordinary share, par value $0.000042 per share
Latest Disclosed Shares Owned: 17,500,000 shares
Security Ownership %: 6.6%

Shares, Excluding Options vs Price

Value, Excluding Options

Armistice Capital, LLC ownership in Autolus Therapeutics plc American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)

17 Feb 2026 - Armistice Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 17,500,000 shares of Autolus Therapeutics plc American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL). This represents 6.6% ownership of the company. In their previous filing dated 14 Nov 2025, ARMISTICE CAPITAL, LLC had reported owning 15,600,000 shares, indicating an increase of +12%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Armistice Capital, LLC	6.6%	+12%	$25,025,000	17,500,000	+1,900,000	+12%	$1.43	13G/A	31 Dec 2025	17 Feb 2026, 21:51
Armistice Capital, LLC	5.9%		$25,428,000	15,600,000			$1.63	13G	30 Sep 2025	14 Nov 2025, 18:38
Armistice Capital, LLC	5%		$2,922,405	1,178,389			$2.48	13G/A	30 Jun 2025	14 Aug 2025, 20:46

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.85%	+0.09%	$34,825,000	17,500,000	+1,900,000	+12%	$1.99	Q4 2025
30 Sep 2025	0.8%	+0.18%	$25,428,000	15,600,000	+3,600,000	+30%	$1.63	Q3 2025
30 Jun 2025	1%	+0.09%	$27,360,000	12,000,000	+1,000,000	+9.1%	$2.28	Q2 2025
31 Mar 2025	0.46%	+0.07%	$17,050,000	11,000,000	+1,800,000		$1.55	Q1 2025
31 Dec 2024	0.5%	+0.13%	$21,620,000	9,200,000	+2,328,000	+34%	$2.35	Q4 2024
30 Sep 2024	0.65%	+0.06%	$24,945,360	6,872,000	+622,000	+10%	$3.63	Q3 2024
30 Jun 2024	0.57%	+0.15%	$21,750,000	6,250,000	+1,578,000	+34%	$3.48	Q2 2024
31 Mar 2024	0.79%	+0.14%	$29,807,360	4,672,000	+822,000	+21%	$6.38	Q1 2024
31 Dec 2023	0.66%	-0.52%	$24,794,000	3,850,000	-3,050,000	-44%	$6.44	Q4 2023
30 Sep 2023	0.48%	-0.03%	$16,077,000	6,900,000	-364,000	-5%	$2.33	Q3 2023
30 Jun 2023	0.43%	-0.14%	$17,288,320	7,264,000	-2,408,000	-25%	$2.38	Q2 2023
31 Mar 2023	0.41%	-0.02%	$17,796,480	9,672,000	-552,000	-5.4%	$1.84	Q1 2023
31 Dec 2022	0.52%	+0.52%	$19,425,600	10,224,000	+10,224,000	NEW	$1.90	Q4 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.